Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
The tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT) trial, 2023 updates.
Anno:
2023
Introduction: the role of beta blockers (BB) post-myocardial infarction (MI) in patients without reduced ejection fraction in the era of invasive management is controversial. Results from observational studies have led to opposite results.  Methods: REBOOT is an independent multinational pragmatic, controlled, randomized, open-label, with blinded endpoint adjudication clinical trial….